A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults
NCT00752687
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C
Interventions
DRUG:
ABT-072
DRUG:
placebo
Sponsor
Abbott